dRx Capital
Verified InteldRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization. dRx Capital currently has 20 portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.
dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization. dRx Capital currently has 20 portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Public Company
- Founded
- Undisclosed
- Employee Bracket
- 1-10
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- CH-4056 Basel
- City
- —
- Region / State
- —
- Postal Code
- —
- Country
- United States
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for dRx Capital.